These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 35745212)
1. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. Shang X; E FF; Guo KL; Li YF; Zhao HL; Wang Y; Chen N; Nian T; Yang CQ; Yang KH; Li XX Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745212 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Goodoory VC; Khasawneh M; Black CJ; Quigley EMM; Moayyedi P; Ford AC Gastroenterology; 2023 Nov; 165(5):1206-1218. PubMed ID: 37541528 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. Didari T; Mozaffari S; Nikfar S; Abdollahi M World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308 [TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials. Wen Y; Li J; Long Q; Yue CC; He B; Tang XG Int J Surg; 2020 Jul; 79():111-119. PubMed ID: 32387213 [TBL] [Abstract][Full Text] [Related]
5. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs. Wang Y; Chen N; Niu F; Li Y; Guo K; Shang X; E F; Yang C; Yang K; Li X Int J Colorectal Dis; 2022 Nov; 37(11):2263-2276. PubMed ID: 36251040 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria. Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis. Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427 [TBL] [Abstract][Full Text] [Related]
9. Probiotics and functional gastrointestinal disorders in children. Vandenplas Y; Benninga M J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120 [TBL] [Abstract][Full Text] [Related]
10. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578 [TBL] [Abstract][Full Text] [Related]
12. Homeopathy for treatment of irritable bowel syndrome. Peckham EJ; Nelson EA; Greenhalgh J; Cooper K; Roberts ER; Agrawal A Cochrane Database Syst Rev; 2013 Nov; (11):CD009710. PubMed ID: 24222383 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials. Niu HL; Xiao JY Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597 [TBL] [Abstract][Full Text] [Related]
15. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis. Sun JR; Kong CF; Qu XK; Deng C; Lou YN; Jia LQ Saudi J Gastroenterol; 2020; 26(2):66-77. PubMed ID: 31898645 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Pratt C; Campbell MD Probiotics Antimicrob Proteins; 2020 Sep; 12(3):834-839. PubMed ID: 31741311 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis. Xu HL; Zou LL; Chen MB; Wang H; Shen WM; Zheng QH; Cui WY PLoS One; 2021; 16(8):e0255160. PubMed ID: 34358238 [TBL] [Abstract][Full Text] [Related]
20. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Xie P; Luo M; Deng X; Fan J; Xiong L Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]